Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

NCT07082842 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

472

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Interventions

DRUG: HEC585
DRUG: Placebo
DRUG: Pirfenidone

Sponsor

Sunshine Lake Pharma Co., Ltd.